Bg pattern

ACNIDUO 1 mg/g + 25 mg/g GEL

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ACNIDUO 1 mg/g + 25 mg/g GEL

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Acniduo 1 mg/g + 25 mg/g gel

adapalene, benzoyl peroxide anhydrous

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Acniduo and what is it used for
  2. What you need to know before you use Acniduo
  3. How to use Acniduo
  4. Possible side effects
  5. Storage of Acniduo
  6. Contents of the pack and other information

1. What is Acniduo and what is it used for

Acniduo is used for the treatment of acne.

This gel combines two active substances, adapalene and benzoyl peroxide, which work together but in different ways:

Adapalene belongs to a group of products known as retinoids and acts specifically on the skin processes that cause acne. The other active substance, benzoyl peroxide, acts as an antimicrobial agent and softens and scales the outer layer of the skin.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before using Acniduo

Do not use Acniduo:

  • if you are allergic to the active substances or to any of the other ingredients of this medicine (listed in section 6).
  • if you are pregnant
  • if you are planning to become pregnant.

Warnings and precautions

Consult your doctor or pharmacist before using Acniduo.

Do not use this medicine on areas where you have cuts, scrapes, sunburns, or eczema.

Make sure this medicine does not come into contact with your eyes, mouth, nostrils, and other sensitive areas of the body. If this happens, rinse these areas immediately with plenty of warm water.

Avoid excessive exposure to sunlight and UV lamps.

Avoid this medicine coming into contact with your hair or colored fabrics, as it may discolor them, and wash your hands well after using the medicine.

The use of Acniduo in children under 9 years of age is not recommended.

Other medicines and Acniduo

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

Do not use other acne products (containing benzoyl peroxide or retinoids) at the same time as this medicine.

Avoid using this medicine at the same time as irritating cosmetics, which dry or exfoliate the skin.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.

Do not usethis medicine if you are pregnant or think you may become pregnant. Your doctor can give you more information.

If you become pregnant while taking this medicine, stop treatment and inform your doctor as soon as possible for follow-up.

This medicine can be used during breastfeeding. To avoid exposure of the baby by contact, application of Acniduo to the breast should be avoided.

Acniduo contains propylene glycol

Acniduo contains 40 mg of propylene glycol in 1 g of gel, which may cause skin irritation.

3. How to use Acniduo

Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

This medicine is only designed for use in adults, adolescents, and children aged 9 years and older. This medicine is for external use only.

Apply a thin layer of gel evenly to the areas affected by acne once a day before going to bed, avoiding the eyes, lips, and nostrils. The skin should be clean and dry before application. Wash your hands well after using this medicine.

One press provides a medium weight of gel of about 0.5 g.

Your doctor will tell you how long you need to use this medicine.

If you think the effect of Acniduo is too strong or too weak, talk to your doctor or pharmacist.

If you experience persistent irritation when applying Acniduo, contact your doctor.

You may be asked to apply a moisturizing cream, use the gel less frequently, or stop using it for a short time, or stop using the gel altogether.

If you use more Acniduo than you should

If you use more Acniduo than you should on the skin, it will not get rid of acne faster, but your skin may become irritated and red.

Contact your doctor or hospital:

  • if you have used more Acniduo than you should
  • if a child has accidentally taken this medicine
  • if you accidentally swallow this medicine.

Your doctor will advise you on the measures to be taken.

If you forget to use Acniduo

Do not apply a double dose to make up for forgotten individual doses.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop using the product and seek medical attention immediately if you experience tightness in the throat or swelling of the eyes, face, lips, or tongue, feel faint, or have difficulty breathing. Stop using the product if you experience hives or itching on the face or body. The frequency of these side effects is unknown.

Common side effects(may affect up to 1 in 10 people):

Dry skin, local skin rash (irritant contact dermatitis), burning sensation, skin irritation, redness, scaling.

Uncommon side effects(may affect up to 1 in 100 people)

Skin itching (pruritus), sunburn.

Unknown(frequency cannot be estimated from the available data):

Swelling of the face, allergic contact reactions, swelling of the eyelids, tightness in the throat, skin pain (stinging), blisters (vesicles), difficulty breathing, skin discoloration (change in skin color), burning at the application site.

If skin irritation occurs after application of Acniduo, it is usually mild to moderate, with local signs such as redness, dryness, scaling, burning, and skin pain (stinging), which reach their peak during the first week and disappear without additional treatment.

Burning at the application site has been reported, mostly superficial but more severe cases, involving the appearance of blisters.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Acniduo

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and bottle after ‘EXP’. The expiry date is the last day of the month stated.

Store below 30°C.

After opening for the first time, this medicine can be used for 6 months if stored at a temperature below 25°C.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

What is in Acniduo

The active substances are adapalene and benzoyl peroxide.

One gram of gel contains 1 mg of adapalene and 25 mg of benzoyl peroxide anhydrous (as benzoyl peroxide, hydrated).

The other ingredients are disodium edetate; sodium docusate; poloxamer 124; glycerol; propylene glycol (E1520); sorbitan oleate; Sepineo P 600 (acrylamide/acrylamidomethyltauric acid copolymer in isohexadecane with polysorbate 80); purified water.

Appearance of Acniduo and contents of the pack

Acniduo 1 mg/g + 25 mg/g gel is a white to very pale yellow opaque gel.

Acniduo 1 mg/g + 25 mg/g gel can be packaged as:

30 g, 45 g, and 60 g of gel in a white polypropylene bottle with a non-air entry pump equipped with an actuator and plastic cap, in a carton.

Not all pack sizes may be marketed.

Marketing authorisation holder

Galenicum Derma, S.L.U.

Crta N-1, Km 36,

28750 San Agustín del Guadalix (Madrid)

Spain

Manufacturer

BELUPO lijekovi i kozmetika, d.d.

Ulica Danica 5

48 000 Croatia

This medicine is authorised in the Member States of the European Economic Area under the following names:

Croatia Acniduo 1 mg/g + 25 mg/g gel

Spain Acniduo 1 mg/g + 25 mg/g gel

This leaflet was last revised in November 2022.

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es

Online doctors for ACNIDUO 1 mg/g + 25 mg/g GEL

Discuss questions about ACNIDUO 1 mg/g + 25 mg/g GEL, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ACNIDUO 1 mg/g + 25 mg/g GEL?
ACNIDUO 1 mg/g + 25 mg/g GEL requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ACNIDUO 1 mg/g + 25 mg/g GEL?
The active ingredient in ACNIDUO 1 mg/g + 25 mg/g GEL is adapalene, combinations. This information helps identify medicines with the same composition but different brand names.
Who manufactures ACNIDUO 1 mg/g + 25 mg/g GEL?
ACNIDUO 1 mg/g + 25 mg/g GEL is manufactured by Galenicum Derma S.L.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ACNIDUO 1 mg/g + 25 mg/g GEL online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ACNIDUO 1 mg/g + 25 mg/g GEL is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ACNIDUO 1 mg/g + 25 mg/g GEL?
Other medicines with the same active substance (adapalene, combinations) include EPIDUO 1 mg/g + 25 mg/g GEL, EPIDUO FORTE 3 mg/g + 25 mg/g GEL, AKLIEF 50 micrograms/g cream. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media